Research Studies

UNC-Chapel Hill Department of Neurology

Myasthenia Gravis

4 studies match your search

Open

IMVT Batoclimab Efficacy and Safety

The purpose of the current Phase 3 study is to confirm the effectiveness and safety of batoclimab in participants with generalized Myasthenia Gravis in 2 different doses of batoclimab compared to placebo.

Learn More

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Study Interest

Brain, Head, Nervous System

Visit Location

Burnett-Womack Building (UNC-Chapel Hill) | Clinical and Translational Research Center (CTRC)

By physician referral or invitation only

Pediatric Ravulizumab Study

To test the effectiveness and safety of the drug ravulizumab in patients aged 6-18 years.

Learn More

Age & Gender

6 years ~ 17 years
Male, Female, Gender Inclusive

Study Interest

Bones, Joints, Muscles
Chronic Conditions

Visit Location

100% Remote (online, phone, text)

By physician referral or invitation only

A Phase 2b, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 3 Dose Levels of NMD670 over 21 Days in Adult Patients with AChR/MuSK-Ab+ Myasthenia Gravis

This study aims to evaluate the efficacy and safety of the drug: NMD670 in adults who have Myasthenia Gravis.

Learn More

Age & Gender

18 years ~ 75 years
Male, Female, Gender Inclusive

Study Interest

Chronic Conditions

Visit Location

100% Remote (online, phone, text)

By physician referral or invitation only

An open-label, outpatient study to evaluate the safe and effective use of a zilucoplan auto-injector for self-administration by study participants with generalized myasthenia gravis

TO EVALUATE THE SAFE AND EFFECTIVE USE OF A ZILUCOPLAN AUTO-INJECTOR COMBINATION PRODUCT FOR SUBCUTANEOUS SELF-ADMINISTRATION BY STUDY PARTICIPANTS

Learn More

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Study Interest

Brain, Head, Nervous System

Visit Location

100% Remote (online, phone, text)

Showing Results 1 - 4 of 4

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.